US Patent 11779602 Methods of use for CAR T cells

Overview Structured Data Issues Contributors Activity

Is a

Patent

Date Filed

January 22, 2019

Date of Patent

October 10, 2023

Patent Application Number

16253562

Patent Citations

‌

US Patent 9765342 Chimeric antigen receptors targeting B-cell maturation antigen

‌

US Patent 9868774 Anti-CD22 chimeric antigen receptors

‌

US Patent 9868951 Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells

‌

US Patent 9873894 Methods and compositions for treatment of a genetic condition

‌

US Patent 9879087 Glycan-interacting compounds and methods of use

‌

US Patent 9885021 Generation of broadly-specific, virus-immune cells targeting multiple HIV antigens for preventive and therapeutic use

‌

US Patent 9889160 Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

‌

US Patent 9889161 Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene

‌

US Patent 9890393 Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system

‌

US Patent 9914909 Costimulatory chimeric antigen receptor T cells targeting IL13Rα2

•••

Patent Inventor Names

Haiyan Chu

James Matthaei

Leroy W. Wheeler, II

Christopher Paul Leamon

Michael C. Jensen

Yingjuan June Lu

Philip Stewart Low

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11779602

Patent Primary Examiner

CPC Code

Find more entities like US Patent 11779602 Methods of use for CAR T cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API